European annals of allergy and clinical immunology · 2011
Sustained clinical efficacy of sublingual immunotherapy with a high-dose grass pollen extract.
Сравнительное исследованиеСтатьяМногоцентровое исследованиеРандомизированное исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kuna P, Samolinski B, Worm M, Pfaar O, Klimek L, Study Group
Аннотация
BACKGROUND: Sublingual immunotherapy (SLIT) with a high-dose 6-grass pollen SingleDose preparation was shown to be effective and safe in a 2-year randomized, double-blind, placebo-controlled trial.
OBJECTIVE: We evaluated the effect of the third year of SLIT in comparison to the second year.
METHODS: 46 grass pollen-allergic patients who had received active treatment for 3 consecutive years were included in the safety set. Diary data from 39 subjects were evaluated to calculate symptom and medication scores as well as 'well days'.
RESULTS: Symptoms and medication intake further decreased in the third year of SLIT during the grass pollen season in comparison to the previous years and the number of 'well days' increased accordingly. No serious adverse events occurred during the three years of SLIT.
CONCLUSION: The third year of SLIT with the high-dose 6-grass pollen preparation results in sustained and even further increased clinical efficacy.
OBJECTIVE: We evaluated the effect of the third year of SLIT in comparison to the second year.
METHODS: 46 grass pollen-allergic patients who had received active treatment for 3 consecutive years were included in the safety set. Diary data from 39 subjects were evaluated to calculate symptom and medication scores as well as 'well days'.
RESULTS: Symptoms and medication intake further decreased in the third year of SLIT during the grass pollen season in comparison to the previous years and the number of 'well days' increased accordingly. No serious adverse events occurred during the three years of SLIT.
CONCLUSION: The third year of SLIT with the high-dose 6-grass pollen preparation results in sustained and even further increased clinical efficacy.